Amniopatch as an active treatment of spontaneous previable rupture of membranes

References

• Yeast JD. Preterm premature rupture of the membranes before viability. Clin Perinatol. 2001;28(4):849–860.
   PubMed Web of Science ®Google Scholar
• Canavan TP, Simhan HN, Caritis S. An evidence-based approach to the evaluation and treatment of premature rupture of membranes. Part I. Obstet Gynecol Surv. 2004;59:669–677.
   PubMedGoogle Scholar
• Lucovnik M, Bregar AT, Steblovnik L, et al. Changes in incidence of iatrogenic and spontaneous preterm births over time: a population-based study. J Perinat Med. 2016;44(5):505–509.
   PubMed Web of Science ®Google Scholar
• McElrath T. Prelabor rupture of membranes before and at the limit of viability. UpToDate 2020 Sep. Available from: https://obgyn.onlinelibrary.wiley.com/hub/journal/14470756/about/author-guidelines.
   Google Scholar
• Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG. 2005;112(Suppl 1):32–37.
   PubMed Web of Science ®Google Scholar
• Quintero RA, Walter JM, Bornick PW, et al. Surgical treatment of spontaneous rupture of membranes: the amniograft-first experience. Am J Obstet Gynecol. 2002;186(1):155–157.
   PubMed Web of Science ®Google Scholar
• Tchirikov M, Schlabritz-Loutsevitch N, Maher J, et al. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018;46(5):465–488.
   PubMed Web of Science ®Google Scholar
• Souza ASR, Patriota AF, Guerra G, et al. Evaluation of perinatal outcomes in pregnant women with preterm premature rupture of membranes. Rev Assoc Med Bras. 2016;62(3):269–275.
   PubMed Web of Science ®Google Scholar
• Mariona FG, Cabero L. Are we ready for a new look at the diagnosis of premature rupture of membranes? J Matern Fetal Neonatal Med. 2012;25(4):403–407.
   PubMed Web of Science ®Google Scholar
• Musilova I, Kutova R, Pliskova L, et al. Intraamniotic inflammation in women with preterm prelabor rupture of membranes. PLoS one. 2015;10(7):e0133929.
   PubMed Web of Science ®Google Scholar
• Ellestad SC, Swamy GK, Sinclair T, et al. Preterm premature rupture of membrane management-inpatient versus outpatient: a retrospective review. Am J Perinatol. 2008;25(1):69–73.
   PubMed Web of Science ®Google Scholar
• Kacerovsky M, Romero R, Stepan M, et al. Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes. Am J Obstet Gynecol. 2020;223(1):114.e1–114.e20.
   PubMed Web of Science ®Google Scholar
• Mukhtar F, Hameed AB, Greenfield S, et al. Perinatal outcomes of pre-viable preterm premature rupture of membranes. J Gyn Obs Bul. 2018;2(1):1–11.
   Google Scholar
• Ferianec V, Krizko M, Jr, Papcun P, et al. Amniopatch – possibility of successful treatment of spontaneous previable rupture of membranes in the second trimester of pregnancy by transabdominal intraamiotic application of platelets and cryoprecipitate. Neuro Endocrinol Lett. 2011;32(4):449–452.
   PubMed Web of Science ®Google Scholar
• Quintero RA, Morales WJ, Allen M, et al. Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): preliminary experience. Am J Obstet Gynecol. 1999;181(3):744–749.
   PubMed Web of Science ®Google Scholar
• Ehsanipoor R. Practice bulletin no. 172: Premature rupture of membranes. Obstet Gynecol. 2016;128(4):e165–e177.
   PubMedGoogle Scholar
• Sciscione A, Manley J, Martin E, et al. Fibrin glue cervical plug as treatment for premature rupture of membranes (PROM) in fetuses <24 weeks’ gestation. Am J Obstet Gynecol. 1998;178:S196.
   PubMed Web of Science ®Google Scholar
• Quintero R, Morales W, Kalter C, et al. Treatment of preterm premature rupture of membranes with an “amniopatch”: preliminary experience. Am J Obstet Gynecol. 1998;178:S197.
   PubMedGoogle Scholar
• Quintero R. New horizons in the treatment of preterm premature rupture of membranes. Clin Perinatol. 2001;28(4):861–875.
   PubMed Web of Science ®Google Scholar
• Quintero R, Romero R, Dzieczkowski J, et al. Sealing of ruptured amniotic membranes with intra-amniotic platelet-cryoprecipitate plug (letter). Lancet. 1996;347(9008):1117.
   PubMed Web of Science ®Google Scholar
• Sung JH, Kuk JY, Cha HH, et al. Amniopatch treatment for preterm premature rupture of membranes before 23 weeks’ gestation and factors associated with its success. Taiwan J Obstet Gynecol. 2017;56(5):599–605.
   PubMed Web of Science ®Google Scholar
• Young BK, Mackenzie AP, Roman AS, et al. Endoscopic closure of fetal membrane defects: comparing iatrogenic versus spontaneous rupture cases. J Matern Fetal Neonatal Med. 2004;16(4):235–240.
   PubMedGoogle Scholar
• Quintero RA. Treatment of previable premature ruptured membranes. Clin Perinatol. 2003;30(3):573–589.
   PubMed Web of Science ®Google Scholar
• Contino B, Armellino F, Brokaj L, et al. Amniopatch, a repairing technique for premature rupture of amniotic membranes in second trimester. Acta BioMed. 2004;75(Suppl. 1):27–30.
   PubMedGoogle Scholar
• Maged AM, Kamel HH, Sanad AS, et al. The value of amniopatch in pregnancies associated with spontaneous preterm premature rupture of fetal membranes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2019;7:1–7.
   Google Scholar
• Kwak HM, Choi HJ, Cha HH, et al. Amniopatch treatment for spontaneous previable, preterm premature rupture of membranes associated or not with incompetent cervix. Fetal Diagn Ther. 2013;33(1):47–54.
   PubMed Web of Science ®Google Scholar
• Fabbro MD, Bortolin M, Taschieri S, et al. Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence. Platelets. 2016;27(4):276–285.
   PubMed Web of Science ®Google Scholar
• Intravia J, Allen DA, Durant TJS, et al. In vitro evaluation of the anti-Bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood. Muscle Ligaments Tendons J. 2019;04(01):79–84.
   Google Scholar
• Badade PS, Mahale SA, Panjwani AA, et al. Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin. Indian J Dent Res. 2016;27(3):300–304.
   PubMedGoogle Scholar
• Drago L, Bortolin M, Vassena C, et al. Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study. PLoS one. 2014;9(9):e107813.
   PubMed Web of Science ®Google Scholar